Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study.

Rheumatol Ther · 2017 · PMC5696287 · PMID 28819927

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

One showed a clear trend for improved short-term outcomes using DR-prednisone as compared to IR-prednisone [ 11 ], and another showed that 7 mg of DR-prednisone given in the evening achieved a similar percentage reduction in mean duration of morning stiffness as achieved with twice the dose of prednisolone in the morning [ 12 ].

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.